Killer immunoglobulin-like receptor 2DS5 is associated with recovery from coronavirus disease 2019

[1]  B. Reinius,et al.  Natural killer cell immunotypes related to COVID-19 disease severity , 2020, Science Immunology.

[2]  Francesco Castelli,et al.  Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics , 2020, The Lancet Infectious Diseases.

[3]  J. Erdmann,et al.  Genomewide Association Study of Severe Covid-19 with Respiratory Failure , 2020, The New England journal of medicine.

[4]  Aaron J. Wilk,et al.  A single-cell atlas of the peripheral immune response in patients with severe COVID-19 , 2020, Nature Medicine.

[5]  J. Rotter,et al.  Predictors of mortality in hospitalized COVID‐19 patients: A systematic review and meta‐analysis , 2020, Journal of medical virology.

[6]  B. Lipworth,et al.  Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19 , 2020, Journal of Allergy and Clinical Immunology.

[7]  Jie Dong,et al.  Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients , 2020, Cell Host & Microbe.

[8]  Fang Liu,et al.  Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19 , 2020, Journal of Clinical Virology.

[9]  Mario Plebani,et al.  Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis , 2020, Clinical chemistry and laboratory medicine.

[10]  T. West,et al.  Covid-19 in Critically Ill Patients in the Seattle Region — Case Series , 2020, The New England journal of medicine.

[11]  Hongyang Wang,et al.  Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing , 2020, Cell Discovery.

[12]  Taojiao Wang,et al.  Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. , 2020, The Journal of clinical investigation.

[13]  Zhigang Tian,et al.  Functional exhaustion of antiviral lymphocytes in COVID-19 patients , 2020, Cellular & Molecular Immunology.

[14]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[15]  Ting Yu,et al.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.

[16]  Killer-Cell Immunoglobulin-Like Receptor , 2020, Definitions.

[17]  Raisa Ntr.  Pandemic Possibilities: A New Facet of Health Diplomacy , 2020, SSRN Electronic Journal.

[18]  R. Liu,et al.  Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors , 2020, Emerging microbes & infections.

[19]  H. Ljunggren,et al.  NK cells are activated and primed for skin-homing during acute dengue virus infection in humans , 2019, Nature Communications.

[20]  H. Ljunggren,et al.  Influenza A Virus Infection Induces Hyperresponsiveness in Human Lung Tissue-Resident and Peripheral Blood NK Cells , 2019, Front. Immunol..

[21]  J. Paul Robinson,et al.  Guidelines for the use of flow cytometry and cell sorting in immunological studies. , 2017, European journal of immunology.

[22]  H. Ljunggren,et al.  NK Cell Responses to Human Tick-Borne Encephalitis Virus Infection , 2016, The Journal of Immunology.

[23]  R. Nanavati,et al.  Diversity in KIR gene repertoire in HIV‐1 exposed infected and uninfected infants: A study from India , 2016, Journal of medical virology.

[24]  J. Gąsiorowski,et al.  The effects of killer cell immunoglobulin-like receptor (KIR) genes on susceptibility to HIV-1 infection in the Polish population , 2016, Immunogenetics.

[25]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[26]  D. Noyola,et al.  Killer-cell immunoglobulin-like receptors (KIR) in severe A (H1N1) 2009 influenza infections , 2012, Immunogenetics.

[27]  H. Ljunggren,et al.  Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus , 2011, The Journal of experimental medicine.

[28]  R. Rajalingam,et al.  A novel real-time PCR method for KIR genotyping. , 2009, Tissue antigens.

[29]  E. Romeo,et al.  Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function , 2008, European journal of immunology.

[30]  S G E Marsh,et al.  Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. , 2003, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[31]  Eric O Long,et al.  A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. , 1997, Journal of immunology.

[32]  Qin Ning,et al.  Clinical and immunological features of severe and moderate coronavirus disease 2019 , 2020 .

[33]  Hongyang Wang,et al.  Erratum: Author Correction: Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. , 2020, Cell discovery.

[34]  M. Carrington,et al.  Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. , 2003, Tissue antigens.

[35]  H. Ljunggren,et al.  In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.